Navigation Links
Pharmacyclics Reports Fiscal 2012 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 53rd American Society of Hematology Annual Meeting
Date:11/7/2011

SUNNYVALE, Calif., Nov. 7, 2011 /PRNewswire/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today reported financial results and recent developments for its fiscal first quarter ended September 30, 2011.

Financial Results for First Quarter Ended September 30, 2011 The non-GAAP (Generally Accepted Accounting Principles) net loss reported for the fiscal quarter ended September 30, 2011 was $12.4 million, or $0.18 per share. This compares with a non-GAAP net loss of $5.4 million, or $0.09 per share, for the fiscal quarter ended September 30, 2010. See "Use of Non-GAAP Financial Measures" below for a description of our Non-GAAP measures.  Reconciliation between certain GAAP and non-GAAP measures is provided at the end of this press release.

The GAAP net loss for the fiscal quarter ended September 30, 2011 was $14.5 million, or $0.21 per share. This compares with a GAAP net loss of $7.5 million, or $0.13 per share for the fiscal quarter ended September 30, 2010.

At September 30, 2011, the company had cash, cash equivalents and marketable securities of $105.2 million, which compares with $112.3 million at June 30, 2011.  

"Making a significant difference for the betterment of patients, their care givers and society is an obligation Team Pharmacyclics considers an honor. We continue to be willing to do whatever it takes, including learning from our successes as well as our mistakes as we proceed on our journey towards sustained viability in service to patients suffering from serious unmet health care needs," said Bob Duggan, CEO and Chairman of the Board.  "We are pleased with how much we have accomplished over the past few years and how well we have done it. We are well into the second quarter of our fiscal year 2012  and the future we are postulating for our stakeholders looks increasingly attainable."

Recent Developments & Highlig
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Pharmacyclics Reports Financial Results and Recent Developments for Fiscal Year and Fourth Quarter 2011 - Conference Call Set for Today at 4:30 PM EDT
2. Pharmacyclics Announces Date of Fiscal Year End 2011 Financial Results and Conference Call
3. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
4. Pharmacyclics Announces Oral Presentations and Clinical Update at Upcoming Medical Meetings
5. Pharmacyclics to Announce Third Quarter Fiscal 2011 Results and Host a Conference Call on May 4, 2011
6. Pharmacyclics to Announce Second Quarter Fiscal 2011 Results and Host a Conference Call on February 4, 2011
7. Pharmacyclics Reports Updated Clinical Results from its Phase IA Trial of its First in Human Btk-Inhibitor PCI-32765
8. Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765
9. Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
10. Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference
11. Pharmacyclics to Present at Bank of America Merrill Lynch Healthcare Conference and MDB Bright Lights Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... SANTA MONICA, Calif. , May 23, 2013 /PRNewswire-USNewswire/ ... of a program that would have required them to ... announced today by Consumer Watchdog and Whatley Kallas LLC.  ... San Diego Superior Court, alleged that Blue Cross,s mandatory ... HIV/AIDS patients, threatening their health and privacy. ...
(Date:5/23/2013)... 2013  Spring Bank Pharmaceuticals, Inc., a biopharmaceutical company ... today announced that it has initiated dosing in a ... daily, oral therapy for the treatment of HCV infection. This ... is designed to assess both the safety and antiviral ... drug for the treatment of chronic HCV infections and ...
(Date:5/23/2013)... -- BioElectronics Corporation (OTC Pink: BIEL), the maker of very ... panel meeting for non-thermal shortwave diathermy: The ... Meeting was held on May 21, 2013 in ... the meeting was very narrow, in that the FDA ... application of non-thermal shortwave diathermy for the treatment of ...
Breaking Medicine Technology:Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2
... 24, 2011 Molecular Devices, Inc. and ChanTest Corporation, ... tools and solutions, have signed an agreement for Molecular ... and GPCR cell lines on a non-exclusive basis.  As ... ChanTest,s ion channel and GPCR cell lines and promote ...
... MELVILLE, N.Y., March 24, 2011 Henry Schein, Inc. ... health care products and services to office-based dental, medical ... the "Wholesalers:  Health Care" industry in Fortune ... the categories of Social Responsibility and Global Competitiveness.  The ...
Cached Medicine Technology:Molecular Devices, Inc. and ChanTest Corporation Sign Cell Line Distribution Agreement 2Molecular Devices, Inc. and ChanTest Corporation Sign Cell Line Distribution Agreement 3Henry Schein Ranks #1 in Its Industry for Social Responsibility as a Fortune 2011 World's Most Admired Company 2Henry Schein Ranks #1 in Its Industry for Social Responsibility as a Fortune 2011 World's Most Admired Company 3
(Date:5/23/2013)... (PRWEB) May 23, 2013 Transvaginal ... Bard, Inc., continue to move forward in a federal ... of West Virginia, Bernstein Liebhard LLP reports. In ... a request by C.R. Bard to seal emails that ... secrets and other confidential, proprietary information about its suppliers. ...
(Date:5/23/2013)... 23, 2013 Click here to read ... start-ups are increasingly seeing their success develop through ... companies, according to new research carried out by ... The company has compiled its research into a series ... of the research have shown the general trend that ...
(Date:5/23/2013)... EnvirOasis, the leader in energy efficient lighting retrofit ... to announce its new line of Energy Star and ... has been a market leader in Fluorescent and ... recently brought to market a full line of LED ... efficient lighting technology which produces a very high light ...
(Date:5/23/2013)... Reporter , , THURSDAY, May 23 (HealthDay News) -- Heavy ... as methamphetamine or crack cocaine, a new study contends. ... or ,coke mouth, it is startling to see the ... same," said Dr. Mohamed Bassiouny, a professor of restorative ... Philadelphia. Methamphetamine, crack cocaine and soda -- sweetened ...
(Date:5/23/2013)... . University ... that can potentially slow the progression of some cancers ... 23 edition of the prestigious journal Cell , ... found that the anti-cancer and anti-proliferative drug rapamycin slows ... monitor the availability of nutrients and will slow down ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 2Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 3Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 2Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 3Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 4Health News:EnvirOasis Lighting Announces Energy Star and Design Lights Consortium LED Products 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3Health News:Scientists discover how rapamycin slows cell growth 2
... - Genomic instability caused by an erosion of the protective ... reinforces those caps, allows malignant cells to evade destruction and ... article at the journal Cell . In ... mice that went through this two-step process developed lethal cancer ...
... (Feb. 21, 2012) With the month of February ... of Cardiology at the Los Angeles Biomedical Research Institute ... Oudiz continue to pave the way with their ... the heart, and to help improve overall heart health. ...
... Even though a colonoscopy is an important colorectal cancer screening ... about the test and avoid it, an expert says. ... see how healthy our insides are," Dr. Christine Hachem, an ... Louis University, said in a university news release. "While you ...
... Alzheimer,s disease drugs now being tested in clinical trials ... Northwestern Medicine research. A study with mice suggests the ... to be miswired and interfering with their ability to ... the scientist whose original research led to the drug ...
... Reporter , FRIDAY, Feb. 17 (HealthDay News) -- Decades-old assumptions about the ... 100 out of reach for many seniors, a new study finds. ... you age. A team of researchers now believe that death ... of flattening out a bit. The findings could lead to new ...
... News) -- ,Eating at least three servings of fish a ... colon polyps, according to a new study. Colon polyps ... into cancer. Previous research has suggested a link between inflammation ... may reduce inflammation and help protect against the development of ...
Cached Medicine News:Health News:Telomere failure, telomerase activation drive prostate cancer progression 2Health News:Telomere failure, telomerase activation drive prostate cancer progression 3Health News:LA BioMed investigators uncover new advancements in cardiovascular medicine 2Health News:Worries About Colonoscopy Unfounded: Study 2Health News:Alzheimer's drugs may have adverse side effects 2Health News:Living to 100 May Be Tougher Than You Think 2Health News:Eating Fish May Help Ward Off Colon Polyps in Women 2
... is produced in the adrenal cortex and, ... DHEA serves as a precursor in testosterone ... androgenic activity, estimated at ~10% that of ... and in adult women, DHEA is an ...
... circulating testosterone exists as unbound or free ... to SHBG with high affinity [1], while ... Both the albumin-bound and free fractions may ... testosterone action. Measurement of the free or ...
... hormone (TSH) is a 32 kDa glycoprotein ... anterior pituitary gland [1]. The structure of ... the pituitary and placental gonadotropins, consisting of ... between these hormones and a unique beta-subunit, ...
... primary active hormone synthesized within the follicular ... is synthesized via a series of steps ... cells, (ii) iodination of tyrosine residues in ... 3-monoiodotyrosine and 3,5-diiodotyrosine (MIT and DIT), and ...
Medicine Products: